Discover how palmitoylation, a tiny molecular tag, rewires prostate cancer metabolism and fuels disease progression through androgen signaling.
Explore an innovative electrochemiluminescent-supramolecular method for detecting sarcosine, a promising biomarker for early prostate cancer diagnosis.
Discover how radiation therapy triggers neuroendocrine differentiation in prostate cancer cells through CREB and ATF2 interplay, leading to treatment resistance.
Discover how Dr. William Nelson's leadership and groundbreaking urine test research at Johns Hopkins are revolutionizing prostate cancer diagnosis and treatment.
Exploring the experimental MUC1-glycopeptide dendritic cell vaccine trial for prostate cancer patients with rising PSA levels after treatment.
Explore how LH-RH analogues work as a biochemical 'off-switch' in advanced prostate cancer treatment through clinical evaluation and research findings.
Discover how 2-amino-5-arylmethyl-1,3-thiazole derivatives show promise as potential therapeutic agents for prostate cancer treatment.
How scientists are using revolutionary 'click chemistry' to build precision gene therapies that hunt down prostate cancer cells.
Discover how 68Ga/177Lu-PSMA I&T is transforming prostate cancer treatment through theranostics, combining precise diagnosis with targeted therapy.
Discover how a groundbreaking serum proteomics approach is revolutionizing prostate cancer diagnosis, moving beyond PSA tests to precise multi-protein signatures.